CJ CheilJedang has patented a modified microorganism from the genus Corynebacterium for producing L-leucine. The microorganism contains a modified polypeptide with specific amino acid substitutions ...
Depression is a leading cause of disability around the world and contributes greatly to the global burden of disease. Nutrition is essential for the maintenance of normal emotional states. Nutritional ...
In Niemann–Pick disease type C, a rare lysosomal storage disorder, treatment with N-acetyl-l-leucine, which may ameliorate lysosomal and metabolic dysfunction, resulted in better neurologic status ...
The company’ss Series A funding round was led by Ecoloab and saw participation from Pravega Ventures, Axilor Ventures, Techstars, and other angel investors The startup will utilise the funding to ...
A PDUFA target date of September 24, 2024 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for IB1001 for the ...
Niemann–Pick disease type C, a lysosomal storage disease, causes progressive neurologic impairment. N-acetyl-l-leucine normalizes cellular energy production and improves lysosomal function. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback